Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.87 - $11.34 $1.22 Million - $2.02 Million
-178,124 Reduced 63.75%
101,308 $725,000
Q1 2024

May 14, 2024

SELL
$5.11 - $8.76 $5.63 Million - $9.65 Million
-1,102,139 Reduced 79.77%
279,432 $2.42 Million
Q4 2023

Feb 13, 2024

SELL
$4.7 - $9.87 $752,094 - $1.58 Million
-160,020 Reduced 10.38%
1,381,571 $9.05 Million
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $3.76 Million - $5.29 Million
411,758 Added 36.44%
1,541,591 $15.4 Million
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $843,724 - $1.05 Million
69,787 Added 6.58%
1,129,833 $14 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $188,952 - $239,718
14,546 Added 1.39%
1,060,046 $14.9 Million
Q4 2022

Feb 13, 2023

BUY
$12.5 - $24.78 $13.1 Million - $25.9 Million
1,045,500 New
1,045,500 $15 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.